IL-17RB: A Potential Drug Target for Various Diseases (G55540)
IL-17RB: A Potential Drug Target for Various Diseases
IL-17RB (Interleukin-17 Receptor B) is a protein that is expressed in various tissues throughout the body, including immune cells, epithelial cells, and nervous cells. It is a member of the IL-17 receptor family, which is a subclass of the IL-1 receptor family. The IL-17 receptor family plays a crucial role in the regulation of immune and inflammatory responses.
IL-17RB is involved in the regulation of immune cell function and cytokine production. It has been shown to promote the development and maintenance of natural killer cells, which are a crucial part of the immune system. IL-17RB has also been shown to regulate the production of pro-inflammatory cytokines, such as TNF-alpha and IL-18.
In addition to its role in immune cell function, IL-17RB is also involved in the regulation of cell survival and angiogenesis. It has been shown to promote the growth and survival of various cell types, including cancer cells. IL-17RB has also been shown to play a role in the regulation of cell migration and the development of tissues.
IL-17RB is a potential drug target for various diseases, including cancer, autoimmune diseases, and neurodegenerative diseases. It is also a potential biomarker for monitoring the effectiveness of certain treatments.
One of the main advantages of IL-17RB as a drug target is its ability to promote the growth and survival of various cell types. This makes it an attractive target for diseases that are characterized by the uncontrolled growth and proliferation of cells, such as cancer. IL-17RB has been shown to promote the growth and survival of cancer cells in cell culture and animal models.
In addition to its ability to promote cell growth and survival, IL-17RB is also involved in the regulation of cell signaling pathways. It has been shown to participate in various signaling pathways, including the TGF-beta pathway and the NF-kB pathway. These pathways are involved in the regulation of cell growth, differentiation, and inflammation.
IL-17RB is also involved in the regulation of cytokine production and immune cell function. It has been shown to regulate the production of pro-inflammatory cytokines, such as TNF-alpha and IL-18. It is also involved in the regulation of immune cell function, including the development and maintenance of natural killer cells.
In conclusion, IL-17RB is a protein that is involved in the regulation of various cellular processes throughout the body. Its ability to promote the growth and survival of cells and its involvement in multiple signaling pathways make it an attractive target for the development of new drugs and therapies. Further research is needed to fully understand the role of IL-17RB in the regulation of cellular processes and its potential as a drug target.
Protein Name: Interleukin 17 Receptor B
Functions: Receptor for the pro-inflammatory cytokines IL17B and IL17E. May play a role in controlling the growth and/or differentiation of hematopoietic cells
The "IL17RB Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about IL17RB comprehensively, including but not limited to:
• general information;
• protein structure and compound binding;
• protein biological mechanisms;
• its importance;
• the target screening and validation;
• expression level;
• disease relevance;
• drug resistance;
• related combination drugs;
• pharmacochemistry experiments;
• related patent analysis;
• advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai
More Common Targets
IL17RC | IL17RD | IL17RE | IL17REL | IL18 | IL18BP | IL18R1 | IL18RAP | IL19 | IL1A | IL1B | IL1F10 | IL1R1 | IL1R2 | IL1RAP | IL1RAPL1 | IL1RAPL2 | IL1RL1 | IL1RL2 | IL1RN | IL2 | IL20 | IL20RA | IL20RB | IL21 | IL21-AS1 | IL21R | IL21R-AS1 | IL22 | IL22RA1 | IL22RA2 | IL23A | IL23R | IL24 | IL25 | IL26 | IL27 | IL27RA | IL2RA | IL2RB | IL2RG | IL3 | IL31 | IL31RA | IL32 | IL33 | IL34 | IL36A | IL36B | IL36G | IL36RN | IL37 | IL3RA | IL4 | IL4I1 | IL4R | IL5 | IL5RA | IL6 | IL6-AS1 | IL6R | IL6R-AS1 | IL6ST | IL6ST-DT | IL6STP1 | IL7 | IL7R | IL9 | IL9R | IL9RP3 | IL9RP4 | ILDR1 | ILDR2 | ILF2 | ILF3 | ILF3-DT | ILK | ILKAP | ILRUN | ILVBL | Imidazoline I2 receptor (I2) | Imidazoline I3 receptor (I3) | Imidazoline receptor | IMMP1L | IMMP2L | IMMT | IMMTP1 | Immunoglobulin A | Immunoglobulin E (IgE) | Immunoglobulin G | Immunoglobulin M | Immunoglobulin-Like Domain Containing Receptor | Immunoproteasome | IMP3 | IMP4 | IMPA1 | IMPA1P1 | IMPA2 | IMPACT | IMPDH1
